Author | No. of patients | Mean at baseline (SD) | Mean at the end (SD) | Mean change vs. baseline | Mean % change vs. baseline |
---|---|---|---|---|---|
Wu et al. [56] placebo | |||||
week 1 | 20 | 20.5(10.4) | 18.5 | 2 | 10 |
week 4 | 20 | 20.5(10.4) | 18.8 | 1.7 | 8 |
week 8 | 20 | 20.5(10.4) | 17.7 | 2.8 | 14 |
week 12 | 20 | 20.5(10.4) | 18.2 | 2.3 | 11 |
Wu et al. [56] BTX-A | |||||
week 1 | 22 | 21.7(22.7) | 8.4 | 13.3 | 61a |
week 4 | 22 | 21.7(22.7) | 4.7 | 17 | 78a |
week 8 | 22 | 21.7(22.7) | 2.3 | 19.4 | 89a |
week 12 | 22 | 21.7(22.7) | 1.8 | 19.9 | 92a |
Bohluli et al. [57] | |||||
week 1 | 15 | 33.0(18.9) | 3.6(5.4) | 29.4 | 89b |
month 1 | 15 | 33.0(18.9) | 4.1(5.8) | 28.9 | 88b |
Türk et al. [59] | |||||
week 1 | 8 | Unclear | Unclear | Unclear | Unclearb |
month 2 | 8 | Unclear | Unclear | Unclear | Unclearb |
month 6 | 8 | Unclear | Unclear | Unclear | Unclearb |